Akm E. Ullah

Array ( [id] => 7324048 [patent_doc_number] => 20040137626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'AAV ITR-mediated modulation' [patent_app_type] => new [patent_app_number] => 10/669641 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4526 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137626.pdf [firstpage_image] =>[orig_patent_app_number] => 10669641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7199975 [patent_doc_number] => 20050042204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Method to protect transgenes from silencing' [patent_app_type] => utility [patent_app_number] => 10/667359 [patent_app_country] => US [patent_app_date] => 2003-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3939 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042204.pdf [firstpage_image] =>[orig_patent_app_number] => 10667359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843076 [patent_doc_number] => 20060121477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Method for detection of micro-metastasis' [patent_app_type] => utility [patent_app_number] => 10/527824 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4793 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121477.pdf [firstpage_image] =>[orig_patent_app_number] => 10527824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7286919 [patent_doc_number] => 20040146935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Disease associated gene' [patent_app_type] => new [patent_app_number] => 10/471567 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8499 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146935.pdf [firstpage_image] =>[orig_patent_app_number] => 10471567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7236229 [patent_doc_number] => 20040073958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Transgenic animal having drug metabolism enzyme gene and utilization thereof' [patent_app_type] => new [patent_app_number] => 10/296242 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12095 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20040073958.pdf [firstpage_image] =>[orig_patent_app_number] => 10296242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7139053 [patent_doc_number] => 20040045041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Means for the identification compounds capable of inhibiting karap-transduced signals' [patent_app_type] => new [patent_app_number] => 10/381018 [patent_app_country] => US [patent_app_date] => 2003-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 15981 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20040045041.pdf [firstpage_image] =>[orig_patent_app_number] => 10381018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7243304 [patent_doc_number] => 20050271637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'BMP-2 estrogen responsive element and methods of using the same' [patent_app_type] => utility [patent_app_number] => 10/642503 [patent_app_country] => US [patent_app_date] => 2003-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11562 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271637.pdf [firstpage_image] =>[orig_patent_app_number] => 10642503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7313067 [patent_doc_number] => 20040143863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Hematopoietic stem cell niche cells' [patent_app_type] => new [patent_app_number] => 10/641319 [patent_app_country] => US [patent_app_date] => 2003-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15452 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20040143863.pdf [firstpage_image] =>[orig_patent_app_number] => 10641319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5776321 [patent_doc_number] => 20060104961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Mechanisms of myoblast transfer in treating heart failure' [patent_app_type] => utility [patent_app_number] => 10/523969 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3481 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20060104961.pdf [firstpage_image] =>[orig_patent_app_number] => 10523969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7393137 [patent_doc_number] => 20040038247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Nucleic acid constructs including a novel t-cell active promoters, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response' [patent_app_type] => new [patent_app_number] => 10/362010 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8969 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038247.pdf [firstpage_image] =>[orig_patent_app_number] => 10362010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894866 [patent_doc_number] => 20060003405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Method of expressing recombinant protein in cho cells' [patent_app_type] => utility [patent_app_number] => 10/521768 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7760 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003405.pdf [firstpage_image] =>[orig_patent_app_number] => 10521768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 658318 [patent_doc_number] => 07105496 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-12 [patent_title] => 'Methods and compositions for inhibiting angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/603387 [patent_app_country] => US [patent_app_date] => 2003-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 46 [patent_no_of_words] => 22509 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105496.pdf [firstpage_image] =>[orig_patent_app_number] => 10603387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7463770 [patent_doc_number] => 20040053299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Regulated activation of cell-membrane receptors by metal-chelating agonists' [patent_app_type] => new [patent_app_number] => 10/451296 [patent_app_country] => US [patent_app_date] => 2003-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5100 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053299.pdf [firstpage_image] =>[orig_patent_app_number] => 10451296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894772 [patent_doc_number] => 20060003311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'In vitro screening of cellular events using 3d cell culture systems' [patent_app_type] => utility [patent_app_number] => 10/517497 [patent_app_country] => US [patent_app_date] => 2003-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10478 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003311.pdf [firstpage_image] =>[orig_patent_app_number] => 10517497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 754129 [patent_doc_number] => 07018834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-28 [patent_title] => 'Mutated herpes simplex virus type 1 thymidine kinases and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/457604 [patent_app_country] => US [patent_app_date] => 2003-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 10724 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/018/07018834.pdf [firstpage_image] =>[orig_patent_app_number] => 10457604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6703279 [patent_doc_number] => 20030226159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Cancer models' [patent_app_type] => new [patent_app_number] => 10/414460 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10800 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20030226159.pdf [firstpage_image] =>[orig_patent_app_number] => 10414460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5822387 [patent_doc_number] => 20060026700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Tissue specific genes and gene clusters' [patent_app_type] => utility [patent_app_number] => 10/511538 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 41681 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20060026700.pdf [firstpage_image] =>[orig_patent_app_number] => 10511538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7433119 [patent_doc_number] => 20040002149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Control of the ratio of LAP to LIP' [patent_app_type] => new [patent_app_number] => 10/410888 [patent_app_country] => US [patent_app_date] => 2003-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14604 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002149.pdf [firstpage_image] =>[orig_patent_app_number] => 10410888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7221375 [patent_doc_number] => 20040072348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Tolerogenic antigen-presenting cells' [patent_app_type] => new [patent_app_number] => 10/402442 [patent_app_country] => US [patent_app_date] => 2003-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9752 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072348.pdf [firstpage_image] =>[orig_patent_app_number] => 10402442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701538 [patent_doc_number] => 20030224418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Genes and polymorphisms associated with cardiovascular disease and their use' [patent_app_type] => new [patent_app_number] => 10/403902 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20078 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224418.pdf [firstpage_image] =>[orig_patent_app_number] => 10403902 [rel_patent_id] =>[rel_patent_doc_number] =>)